LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
12.15
+0.33 (2.79%)
At close: Mar 13, 2026, 4:00 PM EDT
12.14
-0.01 (-0.08%)
After-hours: Mar 13, 2026, 6:51 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $380.17 million as of March 13, 2026. Its market cap has decreased by -35.07% in one year.
Market Cap
380.17M
Enterprise Value
178.96M
1-Year Change
-35.07%
Ranking
Category
Stock Price
$12.15
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $380.17M, a decrease of -8.09%. That is a compound annual growth rate of -4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 380.17M | -24.06% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 399.78M |
| Larimar Therapeutics | 393.29M |
| Kyverna Therapeutics | 391.98M |
| Autolus Therapeutics | 383.25M |
| Armata Pharmaceuticals | 382.92M |
| Niagen Bioscience | 382.78M |
| DiaMedica Therapeutics | 379.12M |
| Aura Biosciences | 377.21M |